RHÖN-KLINIKUM AG Maintains Stability in H1 2026

RHÖN-KLINIKUM AG has reported stable business performance for the first half of 2026. Revenues reached EUR 863.6 million, a slight increase from the previous year. The EBITDA for this period was EUR 57.0 million, with a consolidated profit of EUR 22.5 million. A notable growth in patient treatment occurred, rising by 9% to 513,700 patients.

The company continues to invest in regional health networks, including partnerships like the one between Universitätsklinikum Marburg and Lungenfachklinik Immenhausen in Hesse. These strategic collaborations aim to improve regional healthcare delivery, particularly in specialized areas such as lung care.

Despite the positive financial results, RHÖN-KLINIKUM AG expresses concerns over new regulatory measures, such as the Hospital Reform Adjustment Act, which may impose financial strains. The company projects revenues of EUR 1.7 billion for the full year, with EBITDA expected to range between EUR 110 million and EUR 125 million.